Results of dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema patients: Early versus late switch.

CONCLUSION: In eyes with insufficient response to antivascular endothelial growth factor inhibitors, switching to dexamethasone at the time to 3-monthly antivascular endothelial growth factor inhibitors injections provided better functional outcomes than those that received >3 antivascular endothelial growth factor inhibitors injections.
PMID: 32493065 [PubMed - as supplied by publisher]

Source: European Journal of Ophthalmology - June 2, 2020 Category: Opthalmology Authors: Ruiz-Medrano J, Rodríguez-Leor R, Almazán E, Lugo F, Casado-Lopez E, Arias L, Ruiz-Moreno JM Tags: Eur J Ophthalmol Source Type: research